BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36077723)

  • 1. Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
    Hidalgo-Ríos S; Carrillo-García J; Moura DS; Stacchiotti S; López-Pousa A; Redondo A; Italiano A; Gutiérrez A; Grignani G; Hindi N; López-Guerrero JA; Muro XGD; Trufero JM; Palmerini E; García AS; Bernabeu D; Le Cesne A; Casali PG; Blay JY; Cruz Jurado J; Martin-Broto J
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study.
    Mirili C; Paydaş S; Guney IB; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M; Seydaoglu G
    Cancer Manag Res; 2019; 11():3445-3453. PubMed ID: 31114378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.
    Kara M; Uysal S; Altinişik U; Cevizci S; Güçlü O; Dereköy FS
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):535-542. PubMed ID: 27520567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer.
    Sun Z; Ju Y; Han F; Sun X; Wang F
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer.
    Zhou D; Wu Y; Lin Z; Shi L; Zhao L; Liu T; Yu D; Zhang T
    Gastroenterol Res Pract; 2018; 2018():8042838. PubMed ID: 29643918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer.
    Staniewska E; Tomasik B; Tarnawski R; Łaszczych M; Miszczyk M
    Rep Pract Oncol Radiother; 2021; 26(6):1010-1018. PubMed ID: 34992875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
    Yu J; Ding Z; Yang Y; Liu S
    Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
    Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
    Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red blood cell distribution width in predicting positive surgical margin after laparoscopic radical prostatectomy.
    Wang H; Xie D; Wang S; Wu L; Chu Y; Yang P; He W; Wang J
    Cancer Rep (Hoboken); 2024 Jan; 7(2):e1977. PubMed ID: 38258491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial.
    Napolitano A; Moura DS; Hindi N; Mondaza-Hernandez JL; Merino-Garcia JA; Ramos R; Dagrada GP; Stacchiotti S; Graziano F; Vincenzi B; Martin-Broto J
    Ther Adv Med Oncol; 2022; 14():17588359221116155. PubMed ID: 35965642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.
    Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL
    Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line.
    Espinós J; Aramendía JM; González-Martín A; Santisteban M; Sánchez L; Vizcay Á; Mínguez JÁ; Alcázar JL
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38856872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.
    Bozan N; Alpaycı M; Aslan M; Cankaya H; Kıroglu AF; Turan M; Ayral A; Senkoy E; Ilter S
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3663-3672. PubMed ID: 27034281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
    Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
    Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of absolute lymphocyte/monocyte ratio, red cell distribution width and neutrophil/ lymphocyte ratio in diffuse large B-cell lymphoma patients.
    Hasan KM; Elmeshhedany AY
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):61-68. PubMed ID: 34933732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients.
    Gonçalves JM; Carvalho B; Tuna R; Polónia P; Linhares P
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
    Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
    BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.